NP2 NP2 promotes public health by developing, manufacturing, and distributing affordable medicines targeted at prevention and treatment of diseases in underserved or distressed populations.
NP2 has received 6 grants from 5 known foundation funders. Revenue decreased from $570,351 in 2023 to $58,732 in 2025. Most recent reported revenue: $58,732.
Annual Revenue
$58,732
Known Funders
5
Grants Received
6
Financial History
| Year | Revenue | Expenses | Assets |
|---|---|---|---|
| 2025 | $58,732 | $64,632 | $658,182 |
| 2023 | $570,351 | $282,025 | $858,249 |
| 2022 | $572,902 | $106,933 | $506,971 |
| 2020 | — | $150,141 | $116,104 |
| 2019 | $340,500 | $122,705 | $266,245 |
Top Funders
PALO ALTO, CA
IRVINE, CA
NOVATO, CA
HUDSON, OH
HUDSON, OH
WOODBURY, NY
Key Personnel
From 2025 IRS 990 filing
William Buhles
Dir Emeritus
Jon Nygaard
Director
Joseph Jacobson
Director
Jodi Andrews
Director
Donna Kato
Secretary
David Figg
Treasurer
Jacob P Lalezari
Vice President
Khalid Shah
President
Terri Miller
Exec Director
Frequently Asked Questions
Other Nonprofits in California
Unlock Full Nonprofit Data
Sign up for free to access the complete funder list, financial history, program details, key personnel, and smart matching.